Afluria Quadrivalent FDA Approval History
Last updated by Judith Stewart, BPharm on Oct 28, 2020.
FDA Approved: Yes (First approved August 26, 2016)
Brand name: Afluria Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Treatment for: Influenza Prophylaxis
Afluria Quadrivalent is an inactivated influenza virus vaccine indicated for active immunization against influenza disease in persons 6 months of age and older.
Development Timeline for Afluria Quadrivalent
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.